Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA070769-01
Application #
2114579
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1996-08-01
Project End
2000-05-31
Budget Start
1996-08-01
Budget End
1997-05-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Urology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
de la Taille, A; Katz, A E; Bagiella, E et al. (2000) Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol 113:555-62
de la Taille, A; Cao, Y; Sawczuk, I S et al. (2000) Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion. Cancer Detect Prev 24:579-88
de la Taille, A; Buttyan, R; Hayek, O et al. (2000) Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 164:1229-34
de la Taille, A; Hayek, O R; Burchardt, M et al. (2000) Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J Altern Complement Med 6:449-51
de la Taille, A; Hayek, O; Benson, M C et al. (2000) Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology 55:79-84
de la Taille, A; Katz, A; Cao, Y et al. (2000) Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients. Urology 56:393-8
de la Taille, A; Olsson, C A; Buttyan, R et al. (1999) Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following r Int J Cancer 84:360-4
McKiernan, J M; Buttyan, R; Bander, N H et al. (1999) The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer 86:492-7
de la Taille, A; Hayek, O R; Buttyan, R et al. (1999) Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients. BJU Int 84:845-50
de la Taille, A; Olsson, C A; Buttyan, R et al. (1999) [Columbia University experience of detection of circulating cells by RT-PCR PSA in prostate cancer as a predictive factor of stage and biochemical recurrence] Prog Urol 9:555-61

Showing the most recent 10 out of 15 publications